Interleukin-22 predicts severity and death in advanced liver cirrhosis: a prospective cohort study

BACKGROUND: Interleukin-22 (IL-22), recently identified as a crucial parameter of pathology in experimental liver damage, may determine survival in clinical end-stage liver disease. Systematic analysis of serum IL-22 in relation to morbidity and mortality of patients with advanced liver cirrhosis ha...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Kronenberger, Bernd, Rudloff, Ina, Bachmann, Malte, Brunner, Friederike, Kapper, Lisa, Filmann, Natalie, Waidmann, Oliver, Herrmann, Eva, Pfeilschifter, Josef, Zeuzem, Stefan, Piiper, Albrecht, Mühl, Heiko
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2012
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3519550/
https://ncbi.nlm.nih.gov/pubmed/22967278
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1741-7015-10-102
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak